916MO Safety and efficacy of MEDI0457 plus durvalumab in patients (pts) with human papillomavirus-associated recurrent/metastatic head and neck squamous cell carcinoma (HPV+ R/M HNSCC)
Charu Aggarwal, Nabil F. Saba, Alain P. Algazi, Ammar Sukari, Tanguy Y. Seiwert, Missak Haigentz, Mercedes Porosnicu, Marcelo Bonomi, Jean Boyer, Nicholas M. Durham, Rakesh Kumar, Kevin Laubscher, Min Gong, Natalia Ceaicovscaia, A. Gascó Hernández
Topics & Concepts
MedicineDurvalumabHead and neck squamous-cell carcinomaHuman papillomavirusOncologyHead and neckInternal medicineBasal cellHead and neck cancerCancerImmunotherapySurgeryNivolumabRadiopharmaceutical Chemistry and ApplicationsLung Cancer Treatments and MutationsHead and Neck Cancer Studies